Regional Treatment Flow and Prognosis ofTraumatic Thoracic Aortic Injuries:A Multi-center Retrospective Analysis in Zhejiang Province During 11 Years

NCT ID: NCT04934878

Last Updated: 2021-07-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

234 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-12-19

Study Completion Date

2021-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Using keywords (main) artery dissection aneurysm (main) artery haematoma (main) To diagnose X-ray imaging reports and medical record home page is a search, check the unit 11 hospitals in Zhejiang Province during the year aortic injury clinical data of 11 years, through the electronic questionnaire to fill in the form of information, information of diagnosis and treatment of the basic information for the patient injury mechanism and so on carries on the statistical analysis. Basic information includes gender, age, history of hypertension. Injury information includes injury mechanism information and trauma information. Injury mechanism refers to injuries caused by car accidents, high falls and other causes. Injury information includes diagnosis, injury severity score, Glasgow coma index, and Stanford classification of aortic injury. The information of diagnosis and treatment includes the method of treatment, the reason for referral, the time of definitive treatment and the prognosis. The method of treatment is divided into the first treatment group and the referral group. The first treatment group refers to the patients admitted by the hospital for the first time, and the referral group refers to the patients transferred from other hospitals. The reasons for referral include: the suggestion of the hospital after comprehensive consideration, the lack of diagnosis and treatment qualification of the hospital, the subjective will of the patient's family members. Deterministic treatment time refers to the time from injury to imaging examination and the time from injury to surgery and other data to be statistically analyzed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Severe Trauma Blunt Thoracic Aortic Injury Interventional Therapy Treatment Protocal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Referral information

first visit to our hospital/transfer from another hospital

Referral information

Intervention Type BIOLOGICAL

first visit to our hospital/transfer from another hospital

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Referral information

first visit to our hospital/transfer from another hospital

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of trauma patients with aortic dissection (aortic aneurysm) (aortic hematoma)

Exclusion Criteria

* Patients with primary aortic dissection, limb pseudoaneurysm, non-aortic associated hematoma, etc.Incomplete or lost data, patients refused
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hwa Mei Hospital, University of Chinese Academy of Sciences

UNKNOWN

Sponsor Role collaborator

Zhoushan Hospital Zhejiang Province

UNKNOWN

Sponsor Role collaborator

Taizhou Hospital Zhejiang Province

UNKNOWN

Sponsor Role collaborator

Quzhou People's Hospital Zhejiang Province

UNKNOWN

Sponsor Role collaborator

First Affiliated Hospital of Wenzhou Medical University

OTHER

Sponsor Role collaborator

Second Affiliated Hospital of Wenzhou Medical University

OTHER

Sponsor Role collaborator

Shaoxing People's Hospital

OTHER

Sponsor Role collaborator

Ningbo No. 1 Hospital

OTHER

Sponsor Role collaborator

The Central Hospital of Lishui City

OTHER

Sponsor Role collaborator

Ningbo Medical Center Li Huili Hospital

UNKNOWN

Sponsor Role collaborator

Lishui People's Medical

UNKNOWN

Sponsor Role collaborator

Jinhua Central Hospital

OTHER

Sponsor Role collaborator

903 Hospital of Chinese People's Liberation Army

OTHER

Sponsor Role collaborator

Affiliated Hospital of Jiaxing University

OTHER

Sponsor Role collaborator

The Second Affiliated Hospital of Jiaxing University

OTHER

Sponsor Role collaborator

First People's Hospital of Hangzhou

OTHER

Sponsor Role collaborator

Zhejiang Quhua Hospital

OTHER

Sponsor Role collaborator

Yinzhou Second Hospital

UNKNOWN

Sponsor Role collaborator

Tiantai County People's Hospital

UNKNOWN

Sponsor Role collaborator

Taizhou Hospital

OTHER

Sponsor Role collaborator

The First People's Hospital of Huzhou

OTHER

Sponsor Role collaborator

Suichang County People's Hospital

UNKNOWN

Sponsor Role collaborator

Quzhou Second People's Hospital

UNKNOWN

Sponsor Role collaborator

Ningbo Fenghua District People's Hospital

UNKNOWN

Sponsor Role collaborator

Jiangshan People's Hospital

UNKNOWN

Sponsor Role collaborator

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

SAHZU

Hanzhou, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-859

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Clinical Study of ATTR-CM
NCT04935021 RECRUITING PHASE4